Melo is a behavioural intelligence platform that helps health and social care teams better understand, record, and respond to complex behaviour.
Melo improves the understanding of challenging behaviour across various patient groups (brain injury, dementia, PTSD, learning disability, autism).
Simplified patient assessments, together with graphs and smart analytics, support clinicians in making improved evidence-based care decisions and ultimately, better manage the impact of escalating behaviour patterns and reduce incidents.
Through structured behavioural recording, pattern analysis, and outcome reporting, the platform transforms frontline observations into meaningful insights that support evidence-led, person-centred care.
CareTech has made a strategic investment in Decently, the developer of Melo, recognising the platform's proven impact across NHS, specialist healthcare and complex care environments.
The investment supports continued development, validation, and adoption of innovative technology that improves care outcomes, strengthens clinical decision making, and empowers frontline professionals.
